Related Experiment Videos

[Affinity modification of proteins, binding nucleic acids in mammalian cells, by alkylating derivatives of

Insights

Mammalian cells, including fibroblasts and hepatocytes, possess specific proteins that bind to oligonucleotide derivatives. Researchers identified key binding proteins and quantified their interaction constants, revealing insights into cellular uptake mechanisms.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Context:

  • Oligonucleotide therapeutics require understanding cellular interactions.
  • Specific protein binding influences oligonucleotide uptake and efficacy.
  • Mammalian cells exhibit diverse protein expression profiles.

Purpose:

  • To investigate the interaction of alkylating oligonucleotide derivatives with mammalian cells.
  • To identify and characterize specific oligonucleotide-binding proteins in various cell lines and primary hepatocytes.
  • To quantify the binding affinity of oligonucleotide derivatives to cellular proteins.

Summary:

  • Studies using a 32P-labelled alkylating oligonucleotide derivative, (pT)16, revealed specific protein interactions in multiple mammalian cell lines (COS-1, vero, L-671, Ag 17-1, CHO, B7) and mouse hepatocytes.
  • A 79 kDa protein was identified as common to fibroblastoid cells, while an 83 kDa protein was prominent in Ag 17-1, COS-1 cells, and BALB/c mouse hepatocytes.
  • Binding constants were determined for the alkylating oligonucleotide derivative and its phosphothioate counterpart, with the binding constant for pT16 found to be 5 x 10^6 M^-1.

Impact:

  • Identifies specific cellular targets for oligonucleotide delivery.
  • Provides quantitative data on oligonucleotide-protein binding affinities.
  • Contributes to the rational design of oligonucleotide-based drugs.

Related Concept Videos